Corpus Intelligence IC Memo — ASCENSION ST. VINCENT DUNN 2026-04-27 02:42 UTC
IC Memo — ASCENSION ST. VINCENT DUNN
Investment Committee Memorandum | IN | 25 beds | Grade D | EBITDA uplift $640K
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 151335

ASCENSION ST. VINCENT DUNN

LOCATIONLAWRENCE, IN·BEDS25·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

ASCENSION ST. VINCENT DUNN is a 25-bed under-performing / distressed in LAWRENCE, IN with $8.6M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 24.4% Medicare, 6.2% Medicaid, and 69.4% commercial.

Thesis: Turnaround. Our ML models identify $640K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -101.8% (+745bps).

Net Revenue HCRIS$8.6M
Current EBITDA COMPUTED$-9.4M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS15.3%
Revenue / Bed COMPUTED$344K
Net-to-Gross HCRIS42.4%
Distress Probability ML58.9%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
86
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -100.0% places it below the state median. Among 86 size-comparable peers (12-50 beds), the median margin is -4.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 86 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASCENSION ST. VINCENT DUNN (Target)IN25$8.6M-100.0%
INDIANA ORTHOPAEDIC HOSPITAL LIN38$196.8M31.2%
ORTHOPAEDIC HOSPT.AT PARKVIEWIN37$175.7M36.8%
LUTHERAN MUSCULOSKELETAL CENTEIN39$168.9M25.0%
WITHAM MEMORIAL HOSPITALIN50$158.5M-11.6%
MAJOR HOSPITALIN46$156.9M-9.2%
HENRY COUNTY MEMORIAL HOSPITALIN48$137.8M-1.7%
MARGARET MARY COMMUNITY HOSPITIN25$124.5M-3.6%
KINGS DAUGHTERS HOSPITALIN43$123.4M-13.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $640K (745bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$181K+210bp18mo
Denial Rate Reduction12.0%6.5%$174K+202bp12mo
Cost to Collect4.5%2.5%$172K+200bp12mo
A/R Days Reduction5200.0%3800.0%$105K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+11bp6mo

5. EBITDA Bridge

Net Collection Rate
$181K
Denial Rate Reduction
$174K
Cost to Collect
$172K
A/R Days Reduction
$105K
Clean Claim Rate
$10K
Total EBITDA Uplift$640K
Current EBITDA$-9.4M
+ RCM Uplift+$640K
Pro Forma EBITDA$-8.8M
Current Margin-100.0%
Pro Forma Margin-101.8%
WC Released (1x)$330K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-14.4M$-55.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-14.4M$-65.8M0.00x-100.0%
Bull Case9.0x11.0x$-13.0M$-68.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-13.0M$-78.4M0.00x-100.0%
Bear Case11.0x10.0x$-15.9M$-54.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-15.9M$-64.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 15.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 86 hospitals with 12-50 beds
  • Same-state prioritization (n=87)
  • Comp margins: P25=-14.0% / P50=-4.8% / P75=6.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.